CALCULATE YOUR SIP RETURNS

Dr Agarwals Healthcare Share Price Opens at ₹402 on Listing Day, Feb 4

Written by: Nikitha DeviUpdated on: Feb 5, 2025, 8:54 AM IST
Dr. Agarwal's Healthcare shares were listed at ₹402 and closed at ₹400, marking a 0.50% decline on Feb 4. The stock hit a high of ₹412.90 and a low of ₹370.20.
Dr Agarwals Healthcare Share Price Opens at ₹402 on Listing Day, Feb 4
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Dr Agarwals Healthcare IPO opened for subscription on January 29, 2025, and closed on January 31, 2025.

It was a book-built issue of ₹3,027.26 crore. The issue was a combination of a fresh issue of 0.75 crore shares and an offer for sale of 6.78 crore shares. The Dr Agarwals Healthcare IPO price band was set at ₹382 to ₹402 per share.

On Day 3 of subscription, January 31, as of 5:04 PM, Dr Agarwals Healthcare IPO was subscribed 1.49 times. QIBs subscribed 4.41x, NIIs subscribed 0.39x, and retail investors subscribed 0.42x.

The share allotment was finalised on Monday, February 3, 2025, and the shares were listed on BSE and NSE on Tuesday, February 4, 2025.

Dr Agarwals Healthcare Share Price

On the listing day, on the NSE, Dr Agarwals Healthcare share price (NSE: AGARWALEYE) opened at ₹402.00, the same as its issue price of ₹402.00. The share price closed at ₹400.00, down by 0.50%. The stock touched its day’s high at ₹412.90 and day’s low at ₹370.20. The company’s market cap was ₹12,635.19 crore.

On the BSE, Dr Agarwals Healthcare share price closed at ₹401.55, up by 1.17%. The opening price was ₹396.90.

About Dr. Agarwal’s Health Care Limited

Dr Agarwals provides a comprehensive range of eye care services, such as cataract, refractive, and other surgeries. The company also provides consultations, diagnoses, non-surgical treatments, optical products, contact lenses, accessories, and eye care-related pharmaceutical products.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Feb 5, 2025, 8:54 AM IST

Nikitha Devi

Nikitha is a content creator with 6+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2.5 Cr+ happy customers